Your browser doesn't support javascript.
loading
Author Correction: EZH2 inhibition sensitizes BRG1 and EGFR mutant lung tumours to TopoII inhibitors.
Fillmore, Christine M; Xu, Chunxiao; Desai, Pooja T; Berry, Joanne M; Rowbotham, Samuel P; Lin, Yi-Jang; Zhang, Haikuo; Marquez, Victor E; Hammerman, Peter S; Wong, Kwok-Kin; Kim, Carla F.
Afiliação
  • Fillmore CM; Stem Cell Program, Boston Children's Hospital, Boston, Massachusetts, 02115, USA.
  • Xu C; Department of Genetics, Harvard Medical School, Boston, Massachusetts, 02115, USA.
  • Desai PT; Harvard Stem Cell Institute, Cambridge, Massachusetts, 02138, USA.
  • Berry JM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA.
  • Rowbotham SP; Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, 02115, USA.
  • Lin YJ; Stem Cell Program, Boston Children's Hospital, Boston, Massachusetts, 02115, USA.
  • Zhang H; Stem Cell Program, Boston Children's Hospital, Boston, Massachusetts, 02115, USA.
  • Marquez VE; Stem Cell Program, Boston Children's Hospital, Boston, Massachusetts, 02115, USA.
  • Hammerman PS; Department of Genetics, Harvard Medical School, Boston, Massachusetts, 02115, USA.
  • Wong KK; Harvard Stem Cell Institute, Cambridge, Massachusetts, 02138, USA.
  • Kim CF; Department of Genetics, Harvard Medical School, Boston, Massachusetts, 02115, USA.
Nature ; 563(7732): E27, 2018 11.
Article em En | MEDLINE | ID: mdl-30250255

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Nature Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos